ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
Author: Business Wire
Vesigen to Present New Preclinical Data on Ophthalmology Applications of Engineered ARMMs at 2024 ARVO Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)– #ARMMs–Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today announced that the Company will be presenting tw…
L'Association canadienne des optométristes lance une nouvelle campagne numérique « Faut y voir » pour sensibiliser la population canadienne à la santé oculaire et aux soins de la vue.
OTTAWA, Ontario–(BUSINESS WIRE)–Alors que le mois de mai marque le Mois de la santé visuelle, l’Association canadienne des optométristes (ACO) lance une campagne nationale numérique visant à sensibiliser le public à la santé oculaire et aux soins de …
The Canadian Association of Optometrists Releases a New “GetEyeWise” Digital Campaign to Bring Awareness About Eye Health and Vision Care
OTTAWA, Ontario–(BUSINESS WIRE)–As May marks Vision Health Month, the Canadian Association of Optometrists (CAO) releases a digital national campaign to raise public awareness about eye health and vision care, encouraging Canadians to get their eyes …
STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced Nancy Sabin…
Luxa Biotechnology Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W Therapy for Dry Age-related Macular Degeneration
FORT LEE, N.J.–(BUSINESS WIRE)–Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New York, today announced receipt of a $4 million grant from the Cal…
Bausch + Lomb Announces First-Quarter 2024 Results
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quarter 2024 financial results. “Outperformance from eac…
Surf Bio Announces $1.6 Million Non-Dilutive Grant
PALO ALTO, Calif.–(BUSINESS WIRE)– #biotech–Surf Bio Announces $1.6 Million Non-Dilutive Grant
Heidelberg Engineering Showcases the Future of Imaging, Extending Its Capabilities With a Breadth of Research Technology
HEIDELBERG, Germany–(BUSINESS WIRE)–Heidelberg Engineering welcomes ARVO delegates to experience Heidelberg image quality across a wide range of applications from basic vision research to clinical trials and guided therapy, all with the goal of impro…
Toku Inc. Secures FDA Breakthrough Designation for Technology that Identifies Chronic Kidney Disease Risk Through the Eye
SAN DIEGO–(BUSINESS WIRE)–Toku, Inc., a commercial medical device company specializing in imaging technology and AI, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its MyKidneyAI techno…
Aurion Biotech Announces Completion of Enrollment in Phase 1 / 2 Clinical Trial
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that it has completed dosing of all subjects in its Phase 1 / 2 c…
20/20 Onsite Launches ‘Vision for Southbridge’ Program to Provide Eye Care to All Southbridge, MA Public Schools
BOSTON–(BUSINESS WIRE)–20/20 Onsite, Southbridge Public Schools, and Health Foundation of Central Massachusetts kick off “Vision for Southbridge.”
Inflammasome Therapeutics Announces First Patient Dosed in Geographic Atrophy (GA) Clinical Trial
NEWTON, Mass.–(BUSINESS WIRE)– #NRTIs–Inflammasome Therapeutics (https://www.inflam.com), a private company developing a new class of inflammasome inhibitor drugs, Kamuvudines, as therapies for prevalent, degenerative diseases, announced the first p…
Metropolitan State University of Denver’s Center for Visual Art (CVA) and Department of Art to Offer EnChroma Glasses for Color-blind Students and Visitors
DENVER & BERKELY, Calif.–(BUSINESS WIRE)– #enchroma–Metropolitan State University of Denver Offers EnChroma Glasses to Color Blind Students & Guests; First in State to Help Color Blind College Students
Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced it will host a webcast and confe…
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of 21 scientific poster presentations during the …
STAAR Surgical to Report First Quarter Results on May 7, 2024
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it wil…
EyePromise® Elevates the Standard of Aging Eyecare
CHESTERFIELD, Mo.–(BUSINESS WIRE)–EyePromise, the industry-leading eye health nutraceutical company, has announced the latest updates to its comprehensive nutritional program for eyecare practices. With an eye towards innovation and improvement, EyeP…
LENSRXLAB Secures $830,000 to Develop Two B2B Healthcare Delivery Platforms and Advanced Lens Technology for Diabetics
PHILADELPHIA & JACKSONVILLE, Fla.–(BUSINESS WIRE)– #diabeticeyewear–Ophthalmic Goods Manufacturing startups Bon Vivant Safety Eyewear Company, Inc. and Tioga Optical Lab QOZB, LLC, founded by Anthony B. Miles, US Navy Trident Nuclear Submarine Force…
LENSRXLAB Introduces Groundbreaking Vision Benefits Platform Catered to Diabetic Individuals
PHILADELPHIA–(BUSINESS WIRE)– #benefits–LENSRXLAB, a leading provider of diabetic, safety, and dress eyewear, announces the launch of its Supplemental Vision Benefits Platform for Diabetics, aiming to revolutionize vision care. Founded by a Military…